|
XB--1005168
Papers associated with slc1a2 (and OMIM)
???pagination.result.count???
???pagination.result.page??? 1
Sort Newest To Oldest | Sort Oldest To Newest |
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC, Kambara K, Bertrand D., Expert Opin Drug Discov. February 1, 2024; 19 (2): 173-187. |
|
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease., Iovino L, Giusti V, Pischedda F, Giusto E, Plotegher N, Marte A, Battisti I, Di Iacovo A, Marku A, Piccoli G, Bandopadhyay R, Perego C, Bonifacino T, Bonanno G, Roseti C, Bossi E, Arrigoni G, Bubacco L, Greggio E, Hilfiker S, Civiero L., Acta Neuropathol. July 1, 2022; 144 (1): 81-106. |
|
Interaction of Excitatory Amino Acid Transporters 1 - 3 (EAAT1, EAAT2, EAAT3) with N-Carbamoylglutamate and N-Acetylglutamate., Burckhardt BC, Burckhardt G., Cell Physiol Biochem. January 1, 2017; 43 (5): 1907-1916. |
???pagination.result.page??? 1